Trulieve Cannabis Corp. (TSE:TRU – Free Report) – Research analysts at Seaport Res Ptn issued their Q1 2025 EPS estimates for shares of Trulieve Cannabis in a research note issued on Wednesday, March 5th. Seaport Res Ptn analyst S. Randhawa expects that the company will post earnings per share of ($0.07) for the quarter. Seaport Res Ptn also issued estimates for Trulieve Cannabis’ Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.03) EPS, Q4 2025 earnings at $0.03 EPS, FY2025 earnings at ($0.13) EPS, Q1 2026 earnings at ($0.03) EPS, Q2 2026 earnings at ($0.01) EPS, Q3 2026 earnings at ($0.01) EPS, Q4 2026 earnings at $0.01 EPS and FY2026 earnings at ($0.04) EPS.
TRU has been the subject of several other research reports. Roth Capital raised shares of Trulieve Cannabis to a “strong-buy” rating in a research report on Monday, March 3rd. Atb Cap Markets raised shares of Trulieve Cannabis from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 9th. Cormark raised shares of Trulieve Cannabis from a “hold” rating to a “moderate buy” rating in a research report on Monday, March 3rd. Finally, Craig Hallum raised shares of Trulieve Cannabis to a “strong-buy” rating in a research report on Wednesday, February 26th.
Trulieve Cannabis Stock Performance
Insider Activity at Trulieve Cannabis
In other news, Senior Officer Wes Getman acquired 9,500 shares of the business’s stock in a transaction on Friday, December 13th. The shares were purchased at an average cost of C$7.02 per share, with a total value of C$66,702.35.
Trulieve Cannabis Company Profile
TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.
Featured Articles
- Five stocks we like better than Trulieve Cannabis
- Using the MarketBeat Dividend Tax Calculator
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Business Services Stocks Investing
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Dividend Payout Ratio Calculator
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
